Standard BioTools (LAB) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Seer (SEER) has outperformed Standard BioTools (LAB) over the past year, losing 31.0% versus a loss of 54.3%. Over five years, LAB leads with a -86.5% price change compared with -94.1% for SEER. Standard BioTools is the larger company by market cap ($249.1 million vs $75.9 million), about 3.3 times the size, while Seer is growing revenue faster (+17.0% vs -6.2%).
Standard BioTools converts more of its revenue into profit, with a net margin of -87.8% versus -444.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LAB | SEER |
|---|---|---|
| Share price | $0.631 | $1.36 |
| Market cap | $249.11M | $75.91M |
| 1-day change | +2.82% | -1.81% |
| YTD return | -50.70% | -25.68% |
| 1-year return | -54.28% | -30.96% |
| 5-year return | -86.55% | -94.05% |
| EPS (TTM) | $-0.09 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $85.33M | $16.58M |
| Revenue growth (YoY) | -6.24% | +16.99% |
| Net income (latest FY) | $-74.90M | $-73.60M |
| Gross margin | 49.86% | 51.06% |
| Operating margin | -129.20% | -470.45% |
| Net margin | -87.77% | -443.96% |
| 52-week high | $1.72 | $2.38 |
| 52-week low | $0.39 | $1.33 |
| Distance from 52-week high | -63.31% | -42.74% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +113.95% | +194.12% |
| Average volume | 1.16M | 216.28K |
| Shares outstanding | 394.79M | 55.81M |
| Employees | 385 | 124 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Standard BioTools is about 3.3 times larger than Seer by market value ($249.11M vs $75.91M).
- SEER has outperformed LAB by 23.3 percentage points over the past year.
- Standard BioTools is more profitable, keeping -87.8 cents of every revenue dollar as net income versus -444.0 cents for Seer.
- Seer grew revenue faster in its latest fiscal year (+16.99% vs -6.24%).
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
LAB vs SEER FAQ
Which is bigger, Standard BioTools or Seer?
Standard BioTools (LAB) is larger, with a market capitalization of $249.11M compared with $75.91M for Seer (SEER).
Which stock has performed better over the past year, LAB or SEER?
SEER returned -30.96% over the past 12 months, compared with -54.28% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Standard BioTools and Seer in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.